Biomarker-driven Intermittent Docetaxel in Metastatic Castration-resistant Prostate Cancer

Clinical trial NCT04918810 · TERMINATED

Trial details

NCT number: NCT04918810
Sponsor: Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Castration Resistant Prostatic Cancer

Start date: 2022-07-29
Primary completion: 2024-11-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.